methylprednisolone and calcipotriene

methylprednisolone has been researched along with calcipotriene in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
DiCarlo, JB; Gupta, EA; Solomon, AR	1
Adişen, E; Dursun, A; Erdem, O; Gülekon, A; Gürer, MA	1

Trials

1 trial(s) available for methylprednisolone and calcipotriene

Article	Year
The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:5 Topics: Administration, Topical; Adult; Apoptosis; bcl-2-Associated X Protein; Calcitriol; Dermatologic Agents; Female; Humans; Ki-67 Antigen; Male; Methylprednisolone; Middle Aged; Psoriasis; Statistics, Nonparametric; Treatment Outcome; Tumor Suppressor Protein p53	2006

Article

Year

The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:5

Topics: Administration, Topical; Adult; Apoptosis; bcl-2-Associated X Protein; Calcitriol; Dermatologic Agents; Female; Humans; Ki-67 Antigen; Male; Methylprednisolone; Middle Aged; Psoriasis; Statistics, Nonparametric; Treatment Outcome; Tumor Suppressor Protein p53

2006

Other Studies

2 other study(ies) available for methylprednisolone and calcipotriene

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
A pediatric case of nephrogenic fibrosing dermopathy: improvement after combination therapy. Journal of the American Academy of Dermatology, 2006, Volume: 54, Issue:5 Topics: Administration, Topical; Adolescent; Anti-Inflammatory Agents; Bandages; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Edema; Fibrosis; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Methotrexate; Methylprednisolone; Peritoneal Dialysis; Skin Diseases; Treatment Outcome; Triamcinolone	2006

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

A pediatric case of nephrogenic fibrosing dermopathy: improvement after combination therapy.

Journal of the American Academy of Dermatology, 2006, Volume: 54, Issue:5

Topics: Administration, Topical; Adolescent; Anti-Inflammatory Agents; Bandages; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Edema; Fibrosis; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Methotrexate; Methylprednisolone; Peritoneal Dialysis; Skin Diseases; Treatment Outcome; Triamcinolone

2006